Phase I:
In Vivo Acute Toxicology & Safety Screening of SC1-SC4
Phase II:
Efficacy Screening of SC1-SC4 in a Neuropathic Pain Model
Phase III:
In Vitro DRG SC1-SC4 Safety & Efficacy Screening
Phase IV:
In Vivo Chronic Toxicity Evaluation in Neuropathic Pain Model
Phase V:
In Vivo Efficacy Evaluation a Breast Tumor Model with CIN